FDA Proposed Change to Assessment of Blood Donor Eligibility
The U.S. Food and Drug Administration (FDA) recently proposed “a change from time-based deferrals to assessing blood donor eligibility using gender-inclusive, individual risk-based questions to reduce the risk of transfusion-transmitted HIV.” The draft recommendations are based on FDA’s review of …
FDA Proposed Change to Assessment of Blood Donor Eligibility Read more »
